Association of Atrial Fibrillation With White Matter Disease.
atrial fibrillation
cognitive dysfunction
dementia
leukoencephalopathies
white matter
Journal
Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
pubmed:
19
3
2019
medline:
9
1
2020
entrez:
19
3
2019
Statut:
ppublish
Résumé
Background and Purpose- Evidence suggests that atrial fibrillation (AF) is associated with increased risk of cognitive decline and dementia, even in the absence of stroke. White matter disease (WMD) is a potential mechanism linking AF to cognitive impairment. In this study, we explored the association between prevalent AF and WMD. Methods- We performed a cross-sectional analysis of participants attending the ARIC-NCS (Atherosclerosis Risk in Communities-Neurocognitive Study) in 2011 to 2013 who underwent brain magnetic resonance imaging. AF was ascertained from study visit electrocardiograms or prior hospitalization codes. Extent of WMD was defined by measures of white matter (WM) microstructural integrity and WM hyperintensity volume. Multivariable linear regression models were used to assess the association between AF and WMD. Results- Among 1899 participants (mean age, 76 years; 28% black; 60% women), 133 (7%) had prevalent AF. After multivariable adjustment, differences between participants with and without AF were -0.001 (95% CI, -0.006 to 0.004) for global WM fractional anisotropy, 0.031×10
Identifiants
pubmed: 30879437
doi: 10.1161/STROKEAHA.118.023386
pmc: PMC6433530
mid: NIHMS1522225
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
989-991Subventions
Organisme : NHLBI NIH HHS
ID : U01 HL096812
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL096917
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL096902
Pays : United States
Organisme : American Heart Association-American Stroke Association
ID : 16EIA26410001
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700001I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700004I
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL096814
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL070825
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL096899
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700003I
Pays : United States
Organisme : NIA NIH HHS
ID : K24 AG052573
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700002I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700005I
Pays : United States
Références
Stroke. 2013 Apr;44(4):1020-5
pubmed: 23444303
J Alzheimers Dis. 2015;48(4):987-94
pubmed: 26402108
Behav Neurol. 2009;21(1):39-49
pubmed: 19847044
Neuroscience. 2014 Sep 12;276:206-15
pubmed: 24583036
Neurology. 2013 Mar 5;80(10):911-8
pubmed: 23408873
J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):1-2
pubmed: 28847793
J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):6-13
pubmed: 28554961
Am Heart J. 2009 Jul;158(1):111-7
pubmed: 19540400
Neurology. 2013 Jul 9;81(2):119-25
pubmed: 23739229
Neurotherapeutics. 2007 Jul;4(3):316-29
pubmed: 17599699